Tengion (TNGN) Appoints John Miclot as CEO
Tweet
Share
E-mailGet Alerts TNGN Hot Sheet
Join SI Premium – FREE
Tengion, Inc. (Nasdaq: TNGN), announced the appointment of John L. Miclot as its President and Chief Executive Officer.
Most recently, Miclot was an Executive-in-Residence at Warburg Pincus. He was President and Chief Executive Officer of CCS Medical, Inc., a company owned by Warburg Pincus and a provider of products and services for patients with chronic diseases, from 2008 until completion of a financial restructuring of the company in 2010. From 2003 to 2008, Miclot served as President and Chief Executive Officer of Respironics, Inc., where he developed and implemented a growth strategy that resulted in sale of the company for $5.1 billion to Royal Philips.
Most recently, Miclot was an Executive-in-Residence at Warburg Pincus. He was President and Chief Executive Officer of CCS Medical, Inc., a company owned by Warburg Pincus and a provider of products and services for patients with chronic diseases, from 2008 until completion of a financial restructuring of the company in 2010. From 2003 to 2008, Miclot served as President and Chief Executive Officer of Respironics, Inc., where he developed and implemented a growth strategy that resulted in sale of the company for $5.1 billion to Royal Philips.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Seven Letter adds two staffers to its public affairs practice
- Entrée Resources names Chris Adams as new CEO effective July 17
- W. R. Berkley names Paul Stock president of Carolina Casualty
Create E-mail Alert Related Categories
Management ChangesRelated Entities
Warburg PincusSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
